The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma.
 
Rodabe Amaria
Consulting or Advisory Role - Erasca, Inc; IO Biotech; KSQ Therapeutics; Obsidian Therapeutics; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Erasc (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); OnKure (Inst); Regeneron (Inst)
 
Axel Hauschild
Honoraria - Agenus; Almirall Hermal GmbH; Bristol-Myers Squibb; CureVac; Immunocore; Incyte; IO Biotech; Merck Serono; Merck Sharp & Dohme; NeraCare GmbH; Novartis; Philogen; Pierre Fabre; Regeneron; Replimune; Roche; Sanofi/Aventis; Skyline Diagnostics; Sun Pharma; Xenthera
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Immunocore; IO Biotech; Merck Serono; Merck Sharp & Dohme; Novartis; Philogen; Regeneron; Replimune; Roche; Sanofi/Aventis
Research Funding - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche; Sanofi/Aventis
 
Michael Lowe
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Merck; Regeneron; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Merck (Inst); Regeneron (Inst); Skyline Diagnostics (Inst); Vaccinex (Inst)
 
Janis Taube
Stock and Other Ownership Interests - Akoya Biosciences
Consulting or Advisory Role - Akoya Biosciences; AstraZeneca; Bristol-Myers Squibb; Compugen; Elephas; Lunaphore Technologies; Merck; Moderna Therapeutics; Nextpoint; Regeneron
Research Funding - Akoya Biosciences (Inst); Bristol-Myers Squibb (Inst); NextPoint (Inst)
Patents, Royalties, Other Intellectual Property - image processing of multiplex IF/IHC slides (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck
Other Relationship - Akoya Biosciences
 
Adil Daud
Stock and Other Ownership Interests - Neuvogen; Trex bio
Honoraria - EMD Serono; Inovio Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Genoptix; GlaxoSmithKline; Merck; Oncosec; Pfizer
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Checkmate Pharmaceuticals; Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte; Merck/Schering Plough (Inst); Novartis; oncosec (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - patent relating to test for immunotherapy
 
Thach-Giao Truong
Consulting or Advisory Role - Iovance Biotherapeutics; Merck; Novartis; Pfizer
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Castle Biosciences (Inst); Erasca, Inc (Inst); IDEAYA Biosciences (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis; Perspective Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)
 
Sarah Weiss
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte; Lyell Immunopharma
Research Funding - Apexigen (Inst); Bristol Myers Squibb (Inst)
 
Ankit Mangla
Consulting or Advisory Role - BMSi; SpringWorks Therapeutics
Speakers' Bureau - Springworks Therapeutics
Research Funding - BioAtla; Boehringer Ingelheim; Dragonfly Therapeutics; Pfizer; Regeneron; SpringWorks Therapeutics; TRACON Pharma
 
Tapan Miyani
Employment - Novocure, Regeneron
Stock and Other Ownership Interests - Novocure, Regeneron
 
Deidre Williams
Employment - Regeneron, Inc.
Stock and Other Ownership Interests - Regeneron, Inc.
Travel, Accommodations, Expenses - Regeneron, Inc.
 
Fang Fang
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Shuquan Chen
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Mark Salvati
Employment - Amgen; Regeneron
Stock and Other Ownership Interests - Amgen; Regeneron
 
Israel Lowy
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneron
 
Rossella Marullo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Research Funding - Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)
 
Karl Lewis
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Humberto Lara-Guerra
Employment - Merck Sharp & Dohme; Regeneron
Stock and Other Ownership Interests - Aeglea Biotherapeutics; Merck Sharp & Dohme